Intraoperative Neuromonitoring Market By Products and Services (Systems, Accessories, Services), By Source Type (Insourced Monitoring, Outsourced Monitoring), By Application (Spinal Surgery, Neurosurgery, Orthopedic Surgery, ENT Surgery, Vascular Surgery, Other surgeries), By Modality (Motor evoked potentials (MEPs), Somatosensory evoked potentials (SSEPs), Electroencephalography (EEG), Electromyography (EMG), Brainstem auditory evoked potentials (BAEPs), Visual evoked potentials (VEPs)), By End User (Hospitals, Ambulatory Surgical Centers (ASCs)): Global Opportunity Analysis and Industry Forecast, 2023-2032
The global intraoperative neuromonitoring market was valued at $4,819.15 million in 2022, and is projected to reach $8,729.3 million by 2032, registering a CAGR of 6.1% from 2023 to 2032. Intraoperative neurophysiologic monitoring (IONM) or intraoperative neuromonitoring is a technique to reduce the risk of neurological deficits after surgical procedures that involve the nervous system. IONM utilizes recordings of electrical potentials from the nervous system during surgical procedures. The use of neuromonitoring offers an opportunity to detect injuries before they become severe. Therefore, with the introduction of IONM, the risk of debilitating deficits such as muscle weakness, paralysis, hearing loss, and other loss of normal body functions are reduced.
The major factor driving the growth of the intraoperative neuromonitoring market is prevalence of chronic diseases, encompassing neurological disorders, cardiovascular conditions, and osteoarthritis. These conditions often require surgical intervention, where intraoperative neuromonitoring emerges as a pivotal tool, enhancing surgical precision and minimizing complications. In addition, the rise in number of surgical procedures further drives the market growth. For instance, in 2022, a White Paper from Etiometry Inc., a digital health company, reported that approximately 900,000 cardiac surgeries are performed annually in the U.S., with an average increase in surgery volume of 5% per year. Further, with an aging population, the prevalence of chronic diseases is expected to soar, leading to a higher frequency of complex surgeries. This demographic shift is anticipated to be a key driver, fostering sustained market growth for intraoperative neuromonitoring as an indispensable component of advanced surgical practices.
Moreover, the presence of favorable reimbursement policies significantly contributes to the robust growth of the intraoperative neuromonitoring market. As healthcare systems acknowledge the importance of these monitoring technologies in ensuring patient safety during surgeries, supportive reimbursement frameworks incentivize healthcare providers to integrate intraoperative neuromonitoring into their practices. Reimbursement policies not only alleviate financial burdens on healthcare facilities but also encourage broader adoption, making these advanced monitoring solutions more accessible. This alignment between the benefits of intraoperative neuromonitoring and favorable reimbursement policies serves as a key catalyst, fostering a conducive environment for sustained market expansion.
The intraoperative neuromonitoring market is segmented on the basis of products & services, source type, application, modality, end user, and region. On the basis of product & service, the market is segmented into system, accessory, and service. As per source type, the market is segmented into insourced monitoring and outsourced monitoring. Depending on application, the market is segmented into spinal surgery, neurosurgery, vascular surgery, ENT surgery, orthopedic surgery, and other surgeries. On the basis of modality, the market is segmented into motor evoked potential (MEPs), somatosensory evoked potential (SSEPs), electroencephalography (EEG), electromyography (EMG), brainstem auditory evoked potential (BAEPs), and visual evoked potential (VEPs). According to end user, market is segmented into hospitals and ambulatory surgical centers (ASCs). Region-wise, the market is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, and rest of Europe), Asia-Pacific (China, Japan, India, Australia, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa, and rest of LAMEA).
The major key players that operate in the global intraoperative neuromonitoring market are NuVasive, Inc.,Medtronic plc, Natus Medical Incorporated, inomed Medizintechnik GmbH, Nihon Kohden Corporation, Accurate Monitoring, Computational Diagnostics, Inc., SpecialtyCare, NeuroStyle Pte. Ltd, and Intranerve Neuroscience Holdings, LLC.
Key Benefits For Stakeholders
This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the intraoperative neuromonitoring market analysis from 2022 to 2032 to identify the prevailing intraoperative neuromonitoring market opportunities.
The market research is offered along with information related to key drivers, restraints, and opportunities.
Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
In-depth analysis of the intraoperative neuromonitoring market segmentation assists to determine the prevailing market opportunities.
Major countries in each region are mapped according to their revenue contribution to the global market.
Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
The report includes the analysis of the regional as well as global intraoperative neuromonitoring market trends, key players, market segments, application areas, and market growth strategies.
Key Market Segments
By Products and Services
Systems
Accessories
Services
By Source Type
Insourced Monitoring
Outsourced Monitoring
By Application
Spinal Surgery
Neurosurgery
Orthopedic Surgery
ENT Surgery
Vascular Surgery
Other surgeries
By Modality
Motor evoked potentials (MEPs)
Somatosensory evoked potentials (SSEPs)
Electroencephalography (EEG)
Electromyography (EMG)
Brainstem auditory evoked potentials (BAEPs)
Visual evoked potentials (VEPs)
By End User
Hospitals
Ambulatory Surgical Centers (ASCs)
By Region
North America
U.S.
Canada
Mexico
Europe
Germany
France
UK
Italy
Spain
Rest of Europe
Asia-Pacific
Japan
China
India
Australia
South Korea
Rest of Asia-Pacific
LAMEA
Brazil
Saudi Arabia
South Africa
Rest of LAMEA
Key Market Players
Medtronic plc
inomed Medizintechnik GmbH
Nihon Kohden Corporation
Accurate Monitoring
SpecialtyCare
NeuroStyle Pte.Ltd
Intranerve Neuroscience Holdings, LLC
Natus Medical Incorporated.
Computational Diagnostics, Inc.
NuVasive, Inc.
Please Note: It will take 7-10 business days to complete the report upon order confirmation.
- CHAPTER 1: INTRODUCTION
- 1.1. Report description
- 1.2. Key market segments
- 1.3. Key benefits to the stakeholders
- 1.4. Research methodology
- 1.4.1. Primary research
- 1.4.2. Secondary research
- 1.4.3. Analyst tools and models
- CHAPTER 2: EXECUTIVE SUMMARY
- 2.1. CXO Perspective
- CHAPTER 3: MARKET OVERVIEW
- 3.1. Market definition and scope
- 3.2. Key findings
- 3.2.1. Top impacting factors
- 3.2.2. Top investment pockets
- 3.3. Porter’s five forces analysis
- 3.3.1. Low bargaining power of suppliers
- 3.3.2. Low threat of new entrants
- 3.3.3. Low threat of substitutes
- 3.3.4. Low intensity of rivalry
- 3.3.5. Low bargaining power of buyers
- 3.4. Market dynamics
- 3.4.1. Drivers
- 3.4.1.1. Rise in prevalence of chronic diseases
- 3.4.1.2. Rise in geriatric population
- 3.4.1.3. Applications of IONM in various surgeries
- 3.4.2. Restraints
- 3.4.2.1. Dearth of skilled professionals
- 3.4.3. Opportunities
- 3.4.3.1. Growth opportunities in emerging markets
- CHAPTER 4: INTRAOPERATIVE NEUROMONITORING MARKET, BY PRODUCTS AND SERVICES
- 4.1. Overview
- 4.1.1. Market size and forecast
- 4.2. Systems
- 4.2.1. Key market trends, growth factors and opportunities
- 4.2.2. Market size and forecast, by region
- 4.2.3. Market share analysis by country
- 4.3. Accessories
- 4.3.1. Key market trends, growth factors and opportunities
- 4.3.2. Market size and forecast, by region
- 4.3.3. Market share analysis by country
- 4.4. Services
- 4.4.1. Key market trends, growth factors and opportunities
- 4.4.2. Market size and forecast, by region
- 4.4.3. Market share analysis by country
- CHAPTER 5: INTRAOPERATIVE NEUROMONITORING MARKET, BY SOURCE TYPE
- 5.1. Overview
- 5.1.1. Market size and forecast
- 5.2. Insourced Monitoring
- 5.2.1. Key market trends, growth factors and opportunities
- 5.2.2. Market size and forecast, by region
- 5.2.3. Market share analysis by country
- 5.3. Outsourced Monitoring
- 5.3.1. Key market trends, growth factors and opportunities
- 5.3.2. Market size and forecast, by region
- 5.3.3. Market share analysis by country
- CHAPTER 6: INTRAOPERATIVE NEUROMONITORING MARKET, BY APPLICATION
- 6.1. Overview
- 6.1.1. Market size and forecast
- 6.2. Spinal Surgery
- 6.2.1. Key market trends, growth factors and opportunities
- 6.2.2. Market size and forecast, by region
- 6.2.3. Market share analysis by country
- 6.3. Neurosurgery
- 6.3.1. Key market trends, growth factors and opportunities
- 6.3.2. Market size and forecast, by region
- 6.3.3. Market share analysis by country
- 6.4. Orthopedic Surgery
- 6.4.1. Key market trends, growth factors and opportunities
- 6.4.2. Market size and forecast, by region
- 6.4.3. Market share analysis by country
- 6.5. ENT Surgery
- 6.5.1. Key market trends, growth factors and opportunities
- 6.5.2. Market size and forecast, by region
- 6.5.3. Market share analysis by country
- 6.6. Vascular Surgery
- 6.6.1. Key market trends, growth factors and opportunities
- 6.6.2. Market size and forecast, by region
- 6.6.3. Market share analysis by country
- 6.7. Other surgeries
- 6.7.1. Key market trends, growth factors and opportunities
- 6.7.2. Market size and forecast, by region
- 6.7.3. Market share analysis by country
- CHAPTER 7: INTRAOPERATIVE NEUROMONITORING MARKET, BY MODALITY
- 7.1. Overview
- 7.1.1. Market size and forecast
- 7.2. Motor evoked potentials (MEPs)
- 7.2.1. Key market trends, growth factors and opportunities
- 7.2.2. Market size and forecast, by region
- 7.2.3. Market share analysis by country
- 7.3. Somatosensory evoked potentials (SSEPs)
- 7.3.1. Key market trends, growth factors and opportunities
- 7.3.2. Market size and forecast, by region
- 7.3.3. Market share analysis by country
- 7.4. Electroencephalography (EEG)
- 7.4.1. Key market trends, growth factors and opportunities
- 7.4.2. Market size and forecast, by region
- 7.4.3. Market share analysis by country
- 7.5. Electromyography (EMG)
- 7.5.1. Key market trends, growth factors and opportunities
- 7.5.2. Market size and forecast, by region
- 7.5.3. Market share analysis by country
- 7.6. Brainstem auditory evoked potentials (BAEPs)
- 7.6.1. Key market trends, growth factors and opportunities
- 7.6.2. Market size and forecast, by region
- 7.6.3. Market share analysis by country
- 7.7. Visual evoked potentials (VEPs)
- 7.7.1. Key market trends, growth factors and opportunities
- 7.7.2. Market size and forecast, by region
- 7.7.3. Market share analysis by country
- CHAPTER 8: INTRAOPERATIVE NEUROMONITORING MARKET, BY END USER
- 8.1. Overview
- 8.1.1. Market size and forecast
- 8.2. Hospitals
- 8.2.1. Key market trends, growth factors and opportunities
- 8.2.2. Market size and forecast, by region
- 8.2.3. Market share analysis by country
- 8.3. Ambulatory Surgical Centers (ASCs)
- 8.3.1. Key market trends, growth factors and opportunities
- 8.3.2. Market size and forecast, by region
- 8.3.3. Market share analysis by country
- CHAPTER 9: INTRAOPERATIVE NEUROMONITORING MARKET, BY REGION
- 9.1. Overview
- 9.1.1. Market size and forecast By Region
- 9.2. North America
- 9.2.1. Key market trends, growth factors and opportunities
- 9.2.2. Market size and forecast, by Products and Services
- 9.2.3. Market size and forecast, by Source Type
- 9.2.4. Market size and forecast, by Application
- 9.2.5. Market size and forecast, by Modality
- 9.2.6. Market size and forecast, by End User
- 9.2.7. Market size and forecast, by country
- 9.2.7.1. U.S.
- 9.2.7.1.1. Market size and forecast, by Products and Services
- 9.2.7.1.2. Market size and forecast, by Source Type
- 9.2.7.1.3. Market size and forecast, by Application
- 9.2.7.1.4. Market size and forecast, by Modality
- 9.2.7.1.5. Market size and forecast, by End User
- 9.2.7.2. Canada
- 9.2.7.2.1. Market size and forecast, by Products and Services
- 9.2.7.2.2. Market size and forecast, by Source Type
- 9.2.7.2.3. Market size and forecast, by Application
- 9.2.7.2.4. Market size and forecast, by Modality
- 9.2.7.2.5. Market size and forecast, by End User
- 9.2.7.3. Mexico
- 9.2.7.3.1. Market size and forecast, by Products and Services
- 9.2.7.3.2. Market size and forecast, by Source Type
- 9.2.7.3.3. Market size and forecast, by Application
- 9.2.7.3.4. Market size and forecast, by Modality
- 9.2.7.3.5. Market size and forecast, by End User
- 9.3. Europe
- 9.3.1. Key market trends, growth factors and opportunities
- 9.3.2. Market size and forecast, by Products and Services
- 9.3.3. Market size and forecast, by Source Type
- 9.3.4. Market size and forecast, by Application
- 9.3.5. Market size and forecast, by Modality
- 9.3.6. Market size and forecast, by End User
- 9.3.7. Market size and forecast, by country
- 9.3.7.1. Germany
- 9.3.7.1.1. Market size and forecast, by Products and Services
- 9.3.7.1.2. Market size and forecast, by Source Type
- 9.3.7.1.3. Market size and forecast, by Application
- 9.3.7.1.4. Market size and forecast, by Modality
- 9.3.7.1.5. Market size and forecast, by End User
- 9.3.7.2. France
- 9.3.7.2.1. Market size and forecast, by Products and Services
- 9.3.7.2.2. Market size and forecast, by Source Type
- 9.3.7.2.3. Market size and forecast, by Application
- 9.3.7.2.4. Market size and forecast, by Modality
- 9.3.7.2.5. Market size and forecast, by End User
- 9.3.7.3. UK
- 9.3.7.3.1. Market size and forecast, by Products and Services
- 9.3.7.3.2. Market size and forecast, by Source Type
- 9.3.7.3.3. Market size and forecast, by Application
- 9.3.7.3.4. Market size and forecast, by Modality
- 9.3.7.3.5. Market size and forecast, by End User
- 9.3.7.4. Italy
- 9.3.7.4.1. Market size and forecast, by Products and Services
- 9.3.7.4.2. Market size and forecast, by Source Type
- 9.3.7.4.3. Market size and forecast, by Application
- 9.3.7.4.4. Market size and forecast, by Modality
- 9.3.7.4.5. Market size and forecast, by End User
- 9.3.7.5. Spain
- 9.3.7.5.1. Market size and forecast, by Products and Services
- 9.3.7.5.2. Market size and forecast, by Source Type
- 9.3.7.5.3. Market size and forecast, by Application
- 9.3.7.5.4. Market size and forecast, by Modality
- 9.3.7.5.5. Market size and forecast, by End User
- 9.3.7.6. Rest of Europe
- 9.3.7.6.1. Market size and forecast, by Products and Services
- 9.3.7.6.2. Market size and forecast, by Source Type
- 9.3.7.6.3. Market size and forecast, by Application
- 9.3.7.6.4. Market size and forecast, by Modality
- 9.3.7.6.5. Market size and forecast, by End User
- 9.4. Asia-Pacific
- 9.4.1. Key market trends, growth factors and opportunities
- 9.4.2. Market size and forecast, by Products and Services
- 9.4.3. Market size and forecast, by Source Type
- 9.4.4. Market size and forecast, by Application
- 9.4.5. Market size and forecast, by Modality
- 9.4.6. Market size and forecast, by End User
- 9.4.7. Market size and forecast, by country
- 9.4.7.1. Japan
- 9.4.7.1.1. Market size and forecast, by Products and Services
- 9.4.7.1.2. Market size and forecast, by Source Type
- 9.4.7.1.3. Market size and forecast, by Application
- 9.4.7.1.4. Market size and forecast, by Modality
- 9.4.7.1.5. Market size and forecast, by End User
- 9.4.7.2. China
- 9.4.7.2.1. Market size and forecast, by Products and Services
- 9.4.7.2.2. Market size and forecast, by Source Type
- 9.4.7.2.3. Market size and forecast, by Application
- 9.4.7.2.4. Market size and forecast, by Modality
- 9.4.7.2.5. Market size and forecast, by End User
- 9.4.7.3. India
- 9.4.7.3.1. Market size and forecast, by Products and Services
- 9.4.7.3.2. Market size and forecast, by Source Type
- 9.4.7.3.3. Market size and forecast, by Application
- 9.4.7.3.4. Market size and forecast, by Modality
- 9.4.7.3.5. Market size and forecast, by End User
- 9.4.7.4. Australia
- 9.4.7.4.1. Market size and forecast, by Products and Services
- 9.4.7.4.2. Market size and forecast, by Source Type
- 9.4.7.4.3. Market size and forecast, by Application
- 9.4.7.4.4. Market size and forecast, by Modality
- 9.4.7.4.5. Market size and forecast, by End User
- 9.4.7.5. South Korea
- 9.4.7.5.1. Market size and forecast, by Products and Services
- 9.4.7.5.2. Market size and forecast, by Source Type
- 9.4.7.5.3. Market size and forecast, by Application
- 9.4.7.5.4. Market size and forecast, by Modality
- 9.4.7.5.5. Market size and forecast, by End User
- 9.4.7.6. Rest of Asia-Pacific
- 9.4.7.6.1. Market size and forecast, by Products and Services
- 9.4.7.6.2. Market size and forecast, by Source Type
- 9.4.7.6.3. Market size and forecast, by Application
- 9.4.7.6.4. Market size and forecast, by Modality
- 9.4.7.6.5. Market size and forecast, by End User
- 9.5. LAMEA
- 9.5.1. Key market trends, growth factors and opportunities
- 9.5.2. Market size and forecast, by Products and Services
- 9.5.3. Market size and forecast, by Source Type
- 9.5.4. Market size and forecast, by Application
- 9.5.5. Market size and forecast, by Modality
- 9.5.6. Market size and forecast, by End User
- 9.5.7. Market size and forecast, by country
- 9.5.7.1. Brazil
- 9.5.7.1.1. Market size and forecast, by Products and Services
- 9.5.7.1.2. Market size and forecast, by Source Type
- 9.5.7.1.3. Market size and forecast, by Application
- 9.5.7.1.4. Market size and forecast, by Modality
- 9.5.7.1.5. Market size and forecast, by End User
- 9.5.7.2. Saudi Arabia
- 9.5.7.2.1. Market size and forecast, by Products and Services
- 9.5.7.2.2. Market size and forecast, by Source Type
- 9.5.7.2.3. Market size and forecast, by Application
- 9.5.7.2.4. Market size and forecast, by Modality
- 9.5.7.2.5. Market size and forecast, by End User
- 9.5.7.3. South Africa
- 9.5.7.3.1. Market size and forecast, by Products and Services
- 9.5.7.3.2. Market size and forecast, by Source Type
- 9.5.7.3.3. Market size and forecast, by Application
- 9.5.7.3.4. Market size and forecast, by Modality
- 9.5.7.3.5. Market size and forecast, by End User
- 9.5.7.4. Rest of LAMEA
- 9.5.7.4.1. Market size and forecast, by Products and Services
- 9.5.7.4.2. Market size and forecast, by Source Type
- 9.5.7.4.3. Market size and forecast, by Application
- 9.5.7.4.4. Market size and forecast, by Modality
- 9.5.7.4.5. Market size and forecast, by End User
- CHAPTER 10: COMPETITIVE LANDSCAPE
- 10.1. Introduction
- 10.2. Top winning strategies
- 10.3. Product mapping of top 10 player
- 10.4. Competitive dashboard
- 10.5. Competitive heatmap
- 10.6. Top player positioning, 2022
- CHAPTER 11: COMPANY PROFILES
- 11.1. NuVasive, Inc.
- 11.1.1. Company overview
- 11.1.2. Key executives
- 11.1.3. Company snapshot
- 11.1.4. Operating business segments
- 11.1.5. Product portfolio
- 11.1.6. Business performance
- 11.2. Medtronic plc
- 11.2.1. Company overview
- 11.2.2. Key executives
- 11.2.3. Company snapshot
- 11.2.4. Operating business segments
- 11.2.5. Product portfolio
- 11.2.6. Business performance
- 11.2.7. Key strategic moves and developments
- 11.3. Computational Diagnostics, Inc.
- 11.3.1. Company overview
- 11.3.2. Key executives
- 11.3.3. Company snapshot
- 11.3.4. Operating business segments
- 11.3.5. Product portfolio
- 11.4. Natus Medical Incorporated.
- 11.4.1. Company overview
- 11.4.2. Key executives
- 11.4.3. Company snapshot
- 11.4.4. Operating business segments
- 11.4.5. Product portfolio
- 11.4.6. Business performance
- 11.5. Accurate Monitoring
- 11.5.1. Company overview
- 11.5.2. Key executives
- 11.5.3. Company snapshot
- 11.5.4. Operating business segments
- 11.5.5. Product portfolio
- 11.6. inomed Medizintechnik GmbH
- 11.6.1. Company overview
- 11.6.2. Key executives
- 11.6.3. Company snapshot
- 11.6.4. Operating business segments
- 11.6.5. Product portfolio
- 11.7. Nihon Kohden Corporation
- 11.7.1. Company overview
- 11.7.2. Key executives
- 11.7.3. Company snapshot
- 11.7.4. Operating business segments
- 11.7.5. Product portfolio
- 11.7.6. Business performance
- 11.8. SpecialtyCare
- 11.8.1. Company overview
- 11.8.2. Key executives
- 11.8.3. Company snapshot
- 11.8.4. Operating business segments
- 11.8.5. Product portfolio
- 11.9. Intranerve Neuroscience Holdings, LLC
- 11.9.1. Company overview
- 11.9.2. Key executives
- 11.9.3. Company snapshot
- 11.9.4. Operating business segments
- 11.9.5. Product portfolio
- 11.9.6. Key strategic moves and developments
- 11.10. NeuroStyle Pte.Ltd
- 11.10.1. Company overview
- 11.10.2. Key executives
- 11.10.3. Company snapshot
- 11.10.4. Operating business segments
- 11.10.5. Product portfolio
- LIST OF TABLES
- TABLE 01. GLOBAL INTRAOPERATIVE NEUROMONITORING MARKET, BY PRODUCTS AND SERVICES, 2022-2032 ($MILLION)
- TABLE 02. INTRAOPERATIVE NEUROMONITORING MARKET FOR SYSTEMS, BY REGION, 2022-2032 ($MILLION)
- TABLE 03. INTRAOPERATIVE NEUROMONITORING MARKET FOR ACCESSORIES, BY REGION, 2022-2032 ($MILLION)
- TABLE 04. INTRAOPERATIVE NEUROMONITORING MARKET FOR SERVICES, BY REGION, 2022-2032 ($MILLION)
- TABLE 05. GLOBAL INTRAOPERATIVE NEUROMONITORING MARKET, BY SOURCE TYPE, 2022-2032 ($MILLION)
- TABLE 06. INTRAOPERATIVE NEUROMONITORING MARKET FOR INSOURCED MONITORING, BY REGION, 2022-2032 ($MILLION)
- TABLE 07. INTRAOPERATIVE NEUROMONITORING MARKET FOR OUTSOURCED MONITORING, BY REGION, 2022-2032 ($MILLION)
- TABLE 08. GLOBAL INTRAOPERATIVE NEUROMONITORING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
- TABLE 09. INTRAOPERATIVE NEUROMONITORING MARKET FOR SPINAL SURGERY, BY REGION, 2022-2032 ($MILLION)
- TABLE 10. INTRAOPERATIVE NEUROMONITORING MARKET FOR NEUROSURGERY, BY REGION, 2022-2032 ($MILLION)
- TABLE 11. INTRAOPERATIVE NEUROMONITORING MARKET FOR ORTHOPEDIC SURGERY, BY REGION, 2022-2032 ($MILLION)
- TABLE 12. INTRAOPERATIVE NEUROMONITORING MARKET FOR ENT SURGERY, BY REGION, 2022-2032 ($MILLION)
- TABLE 13. INTRAOPERATIVE NEUROMONITORING MARKET FOR VASCULAR SURGERY, BY REGION, 2022-2032 ($MILLION)
- TABLE 14. INTRAOPERATIVE NEUROMONITORING MARKET FOR OTHER SURGERIES, BY REGION, 2022-2032 ($MILLION)
- TABLE 15. GLOBAL INTRAOPERATIVE NEUROMONITORING MARKET, BY MODALITY, 2022-2032 ($MILLION)
- TABLE 16. INTRAOPERATIVE NEUROMONITORING MARKET FOR MOTOR EVOKED POTENTIALS (MEPS), BY REGION, 2022-2032 ($MILLION)
- TABLE 17. INTRAOPERATIVE NEUROMONITORING MARKET FOR SOMATOSENSORY EVOKED POTENTIALS (SSEPS), BY REGION, 2022-2032 ($MILLION)
- TABLE 18. INTRAOPERATIVE NEUROMONITORING MARKET FOR ELECTROENCEPHALOGRAPHY (EEG), BY REGION, 2022-2032 ($MILLION)
- TABLE 19. INTRAOPERATIVE NEUROMONITORING MARKET FOR ELECTROMYOGRAPHY (EMG), BY REGION, 2022-2032 ($MILLION)
- TABLE 20. INTRAOPERATIVE NEUROMONITORING MARKET FOR BRAINSTEM AUDITORY EVOKED POTENTIALS (BAEPS), BY REGION, 2022-2032 ($MILLION)
- TABLE 21. INTRAOPERATIVE NEUROMONITORING MARKET FOR VISUAL EVOKED POTENTIALS (VEPS), BY REGION, 2022-2032 ($MILLION)
- TABLE 22. GLOBAL INTRAOPERATIVE NEUROMONITORING MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 23. INTRAOPERATIVE NEUROMONITORING MARKET FOR HOSPITALS, BY REGION, 2022-2032 ($MILLION)
- TABLE 24. INTRAOPERATIVE NEUROMONITORING MARKET FOR AMBULATORY SURGICAL CENTERS (ASCS), BY REGION, 2022-2032 ($MILLION)
- TABLE 25. INTRAOPERATIVE NEUROMONITORING MARKET, BY REGION, 2022-2032 ($MILLION)
- TABLE 26. NORTH AMERICA INTRAOPERATIVE NEUROMONITORING MARKET, BY PRODUCTS AND SERVICES, 2022-2032 ($MILLION)
- TABLE 27. NORTH AMERICA INTRAOPERATIVE NEUROMONITORING MARKET, BY SOURCE TYPE, 2022-2032 ($MILLION)
- TABLE 28. NORTH AMERICA INTRAOPERATIVE NEUROMONITORING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
- TABLE 29. NORTH AMERICA INTRAOPERATIVE NEUROMONITORING MARKET, BY MODALITY, 2022-2032 ($MILLION)
- TABLE 30. NORTH AMERICA INTRAOPERATIVE NEUROMONITORING MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 31. NORTH AMERICA INTRAOPERATIVE NEUROMONITORING MARKET, BY COUNTRY, 2022-2032 ($MILLION)
- TABLE 32. U.S. INTRAOPERATIVE NEUROMONITORING MARKET, BY PRODUCTS AND SERVICES, 2022-2032 ($MILLION)
- TABLE 33. U.S. INTRAOPERATIVE NEUROMONITORING MARKET, BY SOURCE TYPE, 2022-2032 ($MILLION)
- TABLE 34. U.S. INTRAOPERATIVE NEUROMONITORING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
- TABLE 35. U.S. INTRAOPERATIVE NEUROMONITORING MARKET, BY MODALITY, 2022-2032 ($MILLION)
- TABLE 36. U.S. INTRAOPERATIVE NEUROMONITORING MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 37. CANADA INTRAOPERATIVE NEUROMONITORING MARKET, BY PRODUCTS AND SERVICES, 2022-2032 ($MILLION)
- TABLE 38. CANADA INTRAOPERATIVE NEUROMONITORING MARKET, BY SOURCE TYPE, 2022-2032 ($MILLION)
- TABLE 39. CANADA INTRAOPERATIVE NEUROMONITORING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
- TABLE 40. CANADA INTRAOPERATIVE NEUROMONITORING MARKET, BY MODALITY, 2022-2032 ($MILLION)
- TABLE 41. CANADA INTRAOPERATIVE NEUROMONITORING MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 42. MEXICO INTRAOPERATIVE NEUROMONITORING MARKET, BY PRODUCTS AND SERVICES, 2022-2032 ($MILLION)
- TABLE 43. MEXICO INTRAOPERATIVE NEUROMONITORING MARKET, BY SOURCE TYPE, 2022-2032 ($MILLION)
- TABLE 44. MEXICO INTRAOPERATIVE NEUROMONITORING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
- TABLE 45. MEXICO INTRAOPERATIVE NEUROMONITORING MARKET, BY MODALITY, 2022-2032 ($MILLION)
- TABLE 46. MEXICO INTRAOPERATIVE NEUROMONITORING MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 47. EUROPE INTRAOPERATIVE NEUROMONITORING MARKET, BY PRODUCTS AND SERVICES, 2022-2032 ($MILLION)
- TABLE 48. EUROPE INTRAOPERATIVE NEUROMONITORING MARKET, BY SOURCE TYPE, 2022-2032 ($MILLION)
- TABLE 49. EUROPE INTRAOPERATIVE NEUROMONITORING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
- TABLE 50. EUROPE INTRAOPERATIVE NEUROMONITORING MARKET, BY MODALITY, 2022-2032 ($MILLION)
- TABLE 51. EUROPE INTRAOPERATIVE NEUROMONITORING MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 52. EUROPE INTRAOPERATIVE NEUROMONITORING MARKET, BY COUNTRY, 2022-2032 ($MILLION)
- TABLE 53. GERMANY INTRAOPERATIVE NEUROMONITORING MARKET, BY PRODUCTS AND SERVICES, 2022-2032 ($MILLION)
- TABLE 54. GERMANY INTRAOPERATIVE NEUROMONITORING MARKET, BY SOURCE TYPE, 2022-2032 ($MILLION)
- TABLE 55. GERMANY INTRAOPERATIVE NEUROMONITORING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
- TABLE 56. GERMANY INTRAOPERATIVE NEUROMONITORING MARKET, BY MODALITY, 2022-2032 ($MILLION)
- TABLE 57. GERMANY INTRAOPERATIVE NEUROMONITORING MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 58. FRANCE INTRAOPERATIVE NEUROMONITORING MARKET, BY PRODUCTS AND SERVICES, 2022-2032 ($MILLION)
- TABLE 59. FRANCE INTRAOPERATIVE NEUROMONITORING MARKET, BY SOURCE TYPE, 2022-2032 ($MILLION)
- TABLE 60. FRANCE INTRAOPERATIVE NEUROMONITORING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
- TABLE 61. FRANCE INTRAOPERATIVE NEUROMONITORING MARKET, BY MODALITY, 2022-2032 ($MILLION)
- TABLE 62. FRANCE INTRAOPERATIVE NEUROMONITORING MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 63. UK INTRAOPERATIVE NEUROMONITORING MARKET, BY PRODUCTS AND SERVICES, 2022-2032 ($MILLION)
- TABLE 64. UK INTRAOPERATIVE NEUROMONITORING MARKET, BY SOURCE TYPE, 2022-2032 ($MILLION)
- TABLE 65. UK INTRAOPERATIVE NEUROMONITORING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
- TABLE 66. UK INTRAOPERATIVE NEUROMONITORING MARKET, BY MODALITY, 2022-2032 ($MILLION)
- TABLE 67. UK INTRAOPERATIVE NEUROMONITORING MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 68. ITALY INTRAOPERATIVE NEUROMONITORING MARKET, BY PRODUCTS AND SERVICES, 2022-2032 ($MILLION)
- TABLE 69. ITALY INTRAOPERATIVE NEUROMONITORING MARKET, BY SOURCE TYPE, 2022-2032 ($MILLION)
- TABLE 70. ITALY INTRAOPERATIVE NEUROMONITORING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
- TABLE 71. ITALY INTRAOPERATIVE NEUROMONITORING MARKET, BY MODALITY, 2022-2032 ($MILLION)
- TABLE 72. ITALY INTRAOPERATIVE NEUROMONITORING MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 73. SPAIN INTRAOPERATIVE NEUROMONITORING MARKET, BY PRODUCTS AND SERVICES, 2022-2032 ($MILLION)
- TABLE 74. SPAIN INTRAOPERATIVE NEUROMONITORING MARKET, BY SOURCE TYPE, 2022-2032 ($MILLION)
- TABLE 75. SPAIN INTRAOPERATIVE NEUROMONITORING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
- TABLE 76. SPAIN INTRAOPERATIVE NEUROMONITORING MARKET, BY MODALITY, 2022-2032 ($MILLION)
- TABLE 77. SPAIN INTRAOPERATIVE NEUROMONITORING MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 78. REST OF EUROPE INTRAOPERATIVE NEUROMONITORING MARKET, BY PRODUCTS AND SERVICES, 2022-2032 ($MILLION)
- TABLE 79. REST OF EUROPE INTRAOPERATIVE NEUROMONITORING MARKET, BY SOURCE TYPE, 2022-2032 ($MILLION)
- TABLE 80. REST OF EUROPE INTRAOPERATIVE NEUROMONITORING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
- TABLE 81. REST OF EUROPE INTRAOPERATIVE NEUROMONITORING MARKET, BY MODALITY, 2022-2032 ($MILLION)
- TABLE 82. REST OF EUROPE INTRAOPERATIVE NEUROMONITORING MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 83. ASIA-PACIFIC INTRAOPERATIVE NEUROMONITORING MARKET, BY PRODUCTS AND SERVICES, 2022-2032 ($MILLION)
- TABLE 84. ASIA-PACIFIC INTRAOPERATIVE NEUROMONITORING MARKET, BY SOURCE TYPE, 2022-2032 ($MILLION)
- TABLE 85. ASIA-PACIFIC INTRAOPERATIVE NEUROMONITORING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
- TABLE 86. ASIA-PACIFIC INTRAOPERATIVE NEUROMONITORING MARKET, BY MODALITY, 2022-2032 ($MILLION)
- TABLE 87. ASIA-PACIFIC INTRAOPERATIVE NEUROMONITORING MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 88. ASIA-PACIFIC INTRAOPERATIVE NEUROMONITORING MARKET, BY COUNTRY, 2022-2032 ($MILLION)
- TABLE 89. JAPAN INTRAOPERATIVE NEUROMONITORING MARKET, BY PRODUCTS AND SERVICES, 2022-2032 ($MILLION)
- TABLE 90. JAPAN INTRAOPERATIVE NEUROMONITORING MARKET, BY SOURCE TYPE, 2022-2032 ($MILLION)
- TABLE 91. JAPAN INTRAOPERATIVE NEUROMONITORING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
- TABLE 92. JAPAN INTRAOPERATIVE NEUROMONITORING MARKET, BY MODALITY, 2022-2032 ($MILLION)
- TABLE 93. JAPAN INTRAOPERATIVE NEUROMONITORING MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 94. CHINA INTRAOPERATIVE NEUROMONITORING MARKET, BY PRODUCTS AND SERVICES, 2022-2032 ($MILLION)
- TABLE 95. CHINA INTRAOPERATIVE NEUROMONITORING MARKET, BY SOURCE TYPE, 2022-2032 ($MILLION)
- TABLE 96. CHINA INTRAOPERATIVE NEUROMONITORING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
- TABLE 97. CHINA INTRAOPERATIVE NEUROMONITORING MARKET, BY MODALITY, 2022-2032 ($MILLION)
- TABLE 98. CHINA INTRAOPERATIVE NEUROMONITORING MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 99. INDIA INTRAOPERATIVE NEUROMONITORING MARKET, BY PRODUCTS AND SERVICES, 2022-2032 ($MILLION)
- TABLE 100. INDIA INTRAOPERATIVE NEUROMONITORING MARKET, BY SOURCE TYPE, 2022-2032 ($MILLION)
- TABLE 101. INDIA INTRAOPERATIVE NEUROMONITORING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
- TABLE 102. INDIA INTRAOPERATIVE NEUROMONITORING MARKET, BY MODALITY, 2022-2032 ($MILLION)
- TABLE 103. INDIA INTRAOPERATIVE NEUROMONITORING MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 104. AUSTRALIA INTRAOPERATIVE NEUROMONITORING MARKET, BY PRODUCTS AND SERVICES, 2022-2032 ($MILLION)
- TABLE 105. AUSTRALIA INTRAOPERATIVE NEUROMONITORING MARKET, BY SOURCE TYPE, 2022-2032 ($MILLION)
- TABLE 106. AUSTRALIA INTRAOPERATIVE NEUROMONITORING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
- TABLE 107. AUSTRALIA INTRAOPERATIVE NEUROMONITORING MARKET, BY MODALITY, 2022-2032 ($MILLION)
- TABLE 108. AUSTRALIA INTRAOPERATIVE NEUROMONITORING MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 109. SOUTH KOREA INTRAOPERATIVE NEUROMONITORING MARKET, BY PRODUCTS AND SERVICES, 2022-2032 ($MILLION)
- TABLE 110. SOUTH KOREA INTRAOPERATIVE NEUROMONITORING MARKET, BY SOURCE TYPE, 2022-2032 ($MILLION)
- TABLE 111. SOUTH KOREA INTRAOPERATIVE NEUROMONITORING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
- TABLE 112. SOUTH KOREA INTRAOPERATIVE NEUROMONITORING MARKET, BY MODALITY, 2022-2032 ($MILLION)
- TABLE 113. SOUTH KOREA INTRAOPERATIVE NEUROMONITORING MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 114. REST OF ASIA-PACIFIC INTRAOPERATIVE NEUROMONITORING MARKET, BY PRODUCTS AND SERVICES, 2022-2032 ($MILLION)
- TABLE 115. REST OF ASIA-PACIFIC INTRAOPERATIVE NEUROMONITORING MARKET, BY SOURCE TYPE, 2022-2032 ($MILLION)
- TABLE 116. REST OF ASIA-PACIFIC INTRAOPERATIVE NEUROMONITORING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
- TABLE 117. REST OF ASIA-PACIFIC INTRAOPERATIVE NEUROMONITORING MARKET, BY MODALITY, 2022-2032 ($MILLION)
- TABLE 118. REST OF ASIA-PACIFIC INTRAOPERATIVE NEUROMONITORING MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 119. LAMEA INTRAOPERATIVE NEUROMONITORING MARKET, BY PRODUCTS AND SERVICES, 2022-2032 ($MILLION)
- TABLE 120. LAMEA INTRAOPERATIVE NEUROMONITORING MARKET, BY SOURCE TYPE, 2022-2032 ($MILLION)
- TABLE 121. LAMEA INTRAOPERATIVE NEUROMONITORING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
- TABLE 122. LAMEA INTRAOPERATIVE NEUROMONITORING MARKET, BY MODALITY, 2022-2032 ($MILLION)
- TABLE 123. LAMEA INTRAOPERATIVE NEUROMONITORING MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 124. LAMEA INTRAOPERATIVE NEUROMONITORING MARKET, BY COUNTRY, 2022-2032 ($MILLION)
- TABLE 125. BRAZIL INTRAOPERATIVE NEUROMONITORING MARKET, BY PRODUCTS AND SERVICES, 2022-2032 ($MILLION)
- TABLE 126. BRAZIL INTRAOPERATIVE NEUROMONITORING MARKET, BY SOURCE TYPE, 2022-2032 ($MILLION)
- TABLE 127. BRAZIL INTRAOPERATIVE NEUROMONITORING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
- TABLE 128. BRAZIL INTRAOPERATIVE NEUROMONITORING MARKET, BY MODALITY, 2022-2032 ($MILLION)
- TABLE 129. BRAZIL INTRAOPERATIVE NEUROMONITORING MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 130. SAUDI ARABIA INTRAOPERATIVE NEUROMONITORING MARKET, BY PRODUCTS AND SERVICES, 2022-2032 ($MILLION)
- TABLE 131. SAUDI ARABIA INTRAOPERATIVE NEUROMONITORING MARKET, BY SOURCE TYPE, 2022-2032 ($MILLION)
- TABLE 132. SAUDI ARABIA INTRAOPERATIVE NEUROMONITORING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
- TABLE 133. SAUDI ARABIA INTRAOPERATIVE NEUROMONITORING MARKET, BY MODALITY, 2022-2032 ($MILLION)
- TABLE 134. SAUDI ARABIA INTRAOPERATIVE NEUROMONITORING MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 135. SOUTH AFRICA INTRAOPERATIVE NEUROMONITORING MARKET, BY PRODUCTS AND SERVICES, 2022-2032 ($MILLION)
- TABLE 136. SOUTH AFRICA INTRAOPERATIVE NEUROMONITORING MARKET, BY SOURCE TYPE, 2022-2032 ($MILLION)
- TABLE 137. SOUTH AFRICA INTRAOPERATIVE NEUROMONITORING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
- TABLE 138. SOUTH AFRICA INTRAOPERATIVE NEUROMONITORING MARKET, BY MODALITY, 2022-2032 ($MILLION)
- TABLE 139. SOUTH AFRICA INTRAOPERATIVE NEUROMONITORING MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 140. REST OF LAMEA INTRAOPERATIVE NEUROMONITORING MARKET, BY PRODUCTS AND SERVICES, 2022-2032 ($MILLION)
- TABLE 141. REST OF LAMEA INTRAOPERATIVE NEUROMONITORING MARKET, BY SOURCE TYPE, 2022-2032 ($MILLION)
- TABLE 142. REST OF LAMEA INTRAOPERATIVE NEUROMONITORING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
- TABLE 143. REST OF LAMEA INTRAOPERATIVE NEUROMONITORING MARKET, BY MODALITY, 2022-2032 ($MILLION)
- TABLE 144. REST OF LAMEA INTRAOPERATIVE NEUROMONITORING MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 145. NUVASIVE, INC.: KEY EXECUTIVES
- TABLE 146. NUVASIVE, INC.: COMPANY SNAPSHOT
- TABLE 147. NUVASIVE, INC.: PRODUCT SEGMENTS
- TABLE 148. NUVASIVE, INC.: PRODUCT PORTFOLIO
- TABLE 149. MEDTRONIC PLC: KEY EXECUTIVES
- TABLE 150. MEDTRONIC PLC: COMPANY SNAPSHOT
- TABLE 151. MEDTRONIC PLC: PRODUCT SEGMENTS
- TABLE 152. MEDTRONIC PLC: PRODUCT PORTFOLIO
- TABLE 153. MEDTRONIC PLC: KEY STRATERGIES
- TABLE 154. COMPUTATIONAL DIAGNOSTICS, INC.: KEY EXECUTIVES
- TABLE 155. COMPUTATIONAL DIAGNOSTICS, INC.: COMPANY SNAPSHOT
- TABLE 156. COMPUTATIONAL DIAGNOSTICS, INC.: SERVICE SEGMENTS
- TABLE 157. COMPUTATIONAL DIAGNOSTICS, INC.: PRODUCT PORTFOLIO
- TABLE 158. NATUS MEDICAL INCORPORATED.: KEY EXECUTIVES
- TABLE 159. NATUS MEDICAL INCORPORATED.: COMPANY SNAPSHOT
- TABLE 160. NATUS MEDICAL INCORPORATED.: PRODUCT SEGMENTS
- TABLE 161. NATUS MEDICAL INCORPORATED.: PRODUCT PORTFOLIO
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook